InsidersTradesSigma
Follow the Nykode Therapeutics ASA stock price and the full insider trade history of the company, a listed equity based in Norway. Shares are quoted on the NO market, under the supervision of Oslo Børs. Operating in the Health Care sector, Nykode Therapeutics ASA has logged 55 public disclosures. The latest transaction was filed on 31 August 2026 (Other). Among the most active insiders: Michael Engsig. All data is free.
55
Insider Decl.
n/a
Thresholds
€47m
25 ops.
Buy Volume
€23m
9 ops.
Sell Volume
10Σ signal
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 31 August 2026
Declarations55 total
OptionXOSLOSLO:679220
600,000 shares@ NOK 7.17920.6% of flowOptionXOSLOSLO:664566
46,356 shares@ NOK 2.1621.2% of flowShareXOSLOSLO:660428
280,000 shares@ NOK 1.8113100.0% of flowShareXOSLOSLO:657002
55,944 shares@ NOK 1.7921.5% of flowShareXOSLOSLO:656985
3,000,000 shares@ NOK 2.138840.2% of flowShareXOSLOSLO:642414
100,000 shares@ NOK 3.001.8% of flowShareXOSLOSLO:635453
5,000,000 shares@ NOK 1.917258.0% of flowShareXOSLOSLO:631746
50,000 shares@ NOK 5.6514.0% of flowShareXOSLOSLO:625848
65,000 shares@ NOK 16.22670.2% of flowOptionXOSLOSLO:619739
25,000 shares@ NOK 14.9749.8% of flowShareXOSLOSLO:614682
20,311 shares@ NOK 15.276100.0% of flowShareXOSLOSLO:614248
10,000 shares@ NOK 14.0029.5% of flowShareXOSLOSLO:613304
25,000 shares@ NOK 14.8150.2% of flowShareXOSLOSLO:613028
40,000 shares@ NOK 13.8128.1% of flowShareXOSLOSLO:612998
20,000 shares@ NOK 16.5970.5% of flowShareXOSLOSLO:612556
6,000 shares@ NOK 16.7121.8% of flowShareXOSLOSLO:612321
@ €0.7486OptionXOSLOSLO:604960
9,850 shares@ NOK 17.1035.5% of flowShareXOSLOSLO:602645
20,000 shares@ NOK 16.3616.1% of flowShareXOSLOSLO:602442
25 of 55 declarations
About Nykode Therapeutics ASA
Nykode Therapeutics ASA is a biopharmaceutical company focused on developing immunotherapies for the treatment of cancer and infectious diseases. It is listed on the XOSL market.
